Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Total Liabilities

$7.18B

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Total Liabilities

Latest reported$7.18Bperiod endingJun 30, 2026

Latest reported$7.18Bperiod endingJun 30, 2026

VRTX Quarterly Total Liabilities ($4.00M → $7.18B)

Quarterly total liabilities

High-resolution chart · PNG

VRTX total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Liabilities — Quarterly (USD)
Period ending	Total Liabilities (USD)
Jun 30, 2001	385,485,000
Mar 31, 2001	378,838,000
Dec 31, 2000	427,125,000
Sep 30, 2000	547,958,000
Jun 30, 2000	203,210,000
Mar 31, 2000	195,194,000
Dec 31, 1999	23,211,000
Sep 30, 1999	18,300,000
Jun 30, 1999	20,000,000
Mar 31, 1999	20,200,000
Dec 31, 1998	20,100,000
Sep 30, 1998	18,800,000
Jun 30, 1998	15,600,000
Mar 31, 1998	14,900,000
Dec 31, 1997	19,600,000
Sep 30, 1997	17,200,000
Jun 30, 1997	14,700,000
Mar 31, 1997	14,400,000
Dec 31, 1996	12,700,000
Sep 30, 1996	9,800,000
Jun 30, 1996	12,000,000
Mar 31, 1996	11,900,000
Dec 31, 1995	13,700,000
Sep 30, 1995	12,700,000
Jun 30, 1995	13,700,000
Mar 31, 1995	10,900,000
Dec 31, 1994	10,700,000
Sep 30, 1994	12,000,000
Jun 30, 1994	11,300,000
Mar 31, 1994	9,400,000
Dec 31, 1993	11,500,000
Sep 30, 1993	10,200,000
Jun 30, 1993	8,400,000
Mar 31, 1993	8,100,000
Dec 31, 1992	7,100,000
Sep 30, 1992	6,400,000
Jun 30, 1992	5,900,000
Mar 31, 1992	4,900,000
Dec 31, 1991	4,900,000
Sep 30, 1991	4,600,000
Jun 30, 1991	4,700,000
Dec 31, 1990	4,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.